-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Contrasting Tivic Health Systems (NASDAQ:TIVC) and BioLife Solutions (NASDAQ:BLFS)
Contrasting Tivic Health Systems (NASDAQ:TIVC) and BioLife Solutions (NASDAQ:BLFS)
Tivic Health Systems (NASDAQ:TIVC – Get Rating) and BioLife Solutions (NASDAQ:BLFS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.
Profitability
This table compares Tivic Health Systems and BioLife Solutions' net margins, return on equity and return on assets.
Get Tivic Health Systems alerts:| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| BioLife Solutions | -67.70% | -7.50% | -6.49% |
Insider and Institutional Ownership
0.2% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 89.8% of BioLife Solutions shares are owned by institutional investors. 14.6% of Tivic Health Systems shares are owned by company insiders. Comparatively, 3.3% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Analyst Recommendations
This is a summary of current ratings and recommmendations for Tivic Health Systems and BioLife Solutions, as reported by MarketBeat.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| BioLife Solutions | 0 | 0 | 1 | 0 | 3.00 |
BioLife Solutions has a consensus target price of $31.20, suggesting a potential upside of 81.82%. Given BioLife Solutions' higher possible upside, analysts clearly believe BioLife Solutions is more favorable than Tivic Health Systems.
Earnings & Valuation
This table compares Tivic Health Systems and BioLife Solutions' revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $1.17 million | 5.05 | -$8.49 million | N/A | N/A |
| BioLife Solutions | $119.16 million | 6.16 | -$7.64 million | ($2.48) | -6.92 |
BioLife Solutions has higher revenue and earnings than Tivic Health Systems.
Summary
BioLife Solutions beats Tivic Health Systems on 9 of the 10 factors compared between the two stocks.
About Tivic Health Systems
(Get Rating)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
About BioLife Solutions
(Get Rating)
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
Tivic Health Systems (NASDAQ:TIVC – Get Rating) and BioLife Solutions (NASDAQ:BLFS – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, valuation, dividends, risk, analyst recommendations and earnings.
Tivic Health Systems(納斯達克：tivc-Get Rating)和BioLife Solutions(納斯達克：BLFS-GET Rating)都是小盤醫療公司，但哪一家更好？我們將根據這兩家公司的盈利能力、機構所有權、估值、股息、風險、分析師建議和收益的強弱進行比較。
Profitability
盈利能力
This table compares Tivic Health Systems and BioLife Solutions' net margins, return on equity and return on assets.
此表比較了Tivic Health Systems和BioLife Solutions的淨利潤率、股本回報率和資產回報率。
| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| BioLife Solutions | -67.70% | -7.50% | -6.49% |
| 淨利潤率 | 股本回報率 | 資產回報率 | |
| Tivic Health Systems | -668.17% | -120.72% | -98.51% |
| 生物生命解決方案 | -67.70% | -7.50% | -6.49% |
Insider and Institutional Ownership
內部人與機構持股
0.2% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 89.8% of BioLife Solutions shares are owned by institutional investors. 14.6% of Tivic Health Systems shares are owned by company insiders. Comparatively, 3.3% of BioLife Solutions shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Tivic Health Systems 0.2%的股份由機構投資者持有。相比之下，BioLife Solutions 89.8%的股份由機構投資者持有。Tivic Health Systems 14.6%的股份由公司內部人士持有。相比之下，BioLife Solutions 3.3%的股份由公司內部人士持有。強大的機構持股表明，對沖基金、大型基金管理公司和捐贈基金相信，一隻股票的長期表現將好於大盤。
Analyst Recommendations
分析師建議
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | N/A |
| BioLife Solutions | 0 | 0 | 1 | 0 | 3.00 |
| 銷售評級 | 保持評級 | 購買評級 | 強勁的買入評級 | 評級分數 | |
| Tivic Health Systems | 0 | 0 | 0 | 0 | 不適用 |
| 生物生命解決方案 | 0 | 0 | 1 | 0 | 3.00 |
BioLife Solutions has a consensus target price of $31.20, suggesting a potential upside of 81.82%. Given BioLife Solutions' higher possible upside, analysts clearly believe BioLife Solutions is more favorable than Tivic Health Systems.
BioLife Solutions的共識目標價為31.20美元，暗示潛在上漲81.82%。考慮到BioLife Solutions更有可能的上行空間，分析師們顯然認為BioLife Solutions比Tivic Health Systems更有利。
Earnings & Valuation
收益與估值
This table compares Tivic Health Systems and BioLife Solutions' revenue, earnings per share and valuation.
此表比較了Tivic Health Systems和BioLife Solutions的收入、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $1.17 million | 5.05 | -$8.49 million | N/A | N/A |
| BioLife Solutions | $119.16 million | 6.16 | -$7.64 million | ($2.48) | -6.92 |
| 總收入 | 價格/銷售額比 | 淨收入 | 每股收益 | 本益比 | |
| Tivic Health Systems | 117萬美元 | 5.05 | -849萬元 | 不適用 | 不適用 |
| 生物生命解決方案 | 1.1916億美元 | 6.16 | -764萬元 | ($2.48) | -6.92 |
BioLife Solutions has higher revenue and earnings than Tivic Health Systems.
BioLife Solutions的收入和收益高於Tivic Health Systems。
Summary
摘要
BioLife Solutions beats Tivic Health Systems on 9 of the 10 factors compared between the two stocks.
BioLife Solutions在兩只股票比較的10個因素中有9個擊敗了Tivic Health Systems。
About Tivic Health Systems
關於Tivic Health Systems
(Get Rating)
(獲取評級)
Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Tivic Health Systems Inc.是一家生物電子設備公司，提供用於治療炎症情況的非侵入性神經調節產品。它的主要產品是Clearup，是一種旨在緩解鼻竇和鼻部炎症的醫療設備。該公司通過自己的網站、亞馬遜(Amazon.com)和沃爾瑪(Walmart.com)等平臺以及BestBuy.com和FSAStore.com等美國在線零售商，通過直接面向消費者的渠道銷售產品。Tivic Health Systems，Inc.成立於2016年，總部設在加利福尼亞州海沃德。
About BioLife Solutions
關於BioLife解決方案
(Get Rating)
(獲取評級)
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
BioLife Solutions，Inc.致力於細胞和組織生物保存工具的開發、製造和營銷。其產品包括用於細胞、組織和器官的專有低溫儲存和冷凍保存冷凍介質產品，通用血液幹細胞冷凍和細胞解凍介質產品，以及定製產品配方和定製包裝服務。該公司由鮑裡斯·魯賓斯基於1987年創立，總部設在華盛頓州博塞爾。
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
接受Tivic Health Systems Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Tivic Health Systems和相關公司的最新新聞和分析師評級的每日簡明摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧